HindBio Science Stock Price Today (NSE: HINDIBIO)
Fundamental Score
HindBio Science Share Price — Live NSE/BSE Price, Fundamentals & Analysis
HindBio Science share price today is ₹5.80, up +0.00% on NSE/BSE as of 2 January 2026. HindBio Science (HINDIBIO) is a Small-cap company in the Software Products sector with a market capitalisation of ₹5.94 (Cr). The 52-week high for HINDIBIO share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 297.13x, HINDIBIO is currently trading above its industry average P/E of 36.75x. The company has a Return on Equity (ROE) of 11.76% and a debt-to-equity ratio of 3.05.
HindBio Science Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
HindBio Science Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
HindBio Science Share Price: A ROCE-Focused Analysis
The software products industry, while boasting high scalability, often witnesses a significant divergence in profitability based on efficient capital allocation. This analysis examines the current standing of the HindBio Science share price, trading at ₹5.8, particularly in light of its Return on Capital Employed (ROCE) and compares it to sector peers.
With a Price-to-Earnings (PE) ratio of 297.13 and a ROCE of 2.95%, HindBio Science presents a contrasting picture. A high PE ratio typically suggests investor expectations of future growth, but this needs to be contextualized with its ROCE. The relatively low ROCE indicates that for every rupee invested in the business, HindBio Science is generating a return of only 2.95 paisa. This raises questions about the efficiency of capital utilization within the company. A robust ROCE is crucial for building a sustainable competitive advantage, or "moat," and the current 2.95% suggests that HindBio Science's moat is relatively shallow, making it more vulnerable to competition and economic downturns.
Comparing HindBio Science to its peers provides further context. While data for Infronics Systems Ltd and Silicon Valley is unavailable for this analysis, considering
Aion Tech Solutions Ltd, differences in ROCE often reflect variations in management quality. Aion Tech Solutions Ltd might demonstrate better capital allocation strategies, resulting in a higher ROCE and potentially justifying a premium valuation. Management's ability to effectively deploy capital and generate returns is a critical driver of long-term shareholder value.This ROCE efficiency analysis is part of a broader, 80-parameter fundamental audit conducted to assess the financial health and performance of HindBio Science. This audit was verified by Sweta Mishra. The analysis presented here is purely observational and based on publicly available data. It is not intended to provide any buy or sell recommendations.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
HindBio Science Fundamental Analysis & Valuation Benchmarking
Educational evaluation of HINDIBIO across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
12 factors identified
Suboptimal ROCE (2.95%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-31.13%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 297.13x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-175.00%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-100.00%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-16.03% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (4.56% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (4.56% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Elevated Debt Levels (D/E: 3.05)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Negative Free Cash Flow (₹-1.02 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (12.19%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
HindBio Science Financial Statements
Comprehensive financial data for HindBio Science including income statement, balance sheet and cash flow
About HINDIBIO (HindBio Science)
HindBio Science (HINDIBIO) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Software Products sector with a curr...ent market capitalisation of ₹5.94 (Cr). HindBio Science has delivered a Return on Equity (ROE) of 11.76% and a ROCE of 2.95%. The debt-to-equity ratio stands at 3.05, reflecting the company's capital structure. Investors tracking HINDIBIO share price can monitor key metrics including P/E ratio, promoter holding of 12.19%, and quarterly earnings growth.
Company Details
HINDIBIO Share Price: Frequently Asked Questions
What is the current share price of HindBio Science (HINDIBIO)?
As of 02 Jan 2026, 03:53 pm IST, HindBio Science share price is ₹5.80. The HINDIBIO stock has a market capitalisation of ₹5.94 (Cr) on NSE/BSE.
Is HINDIBIO share price Overvalued or Undervalued?
HINDIBIO share price is currently trading at a P/E ratio of 297.13x, compared to the industry average of 36.75x. Based on this relative valuation, the HindBio Science stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of HINDIBIO share price?
The 52-week high of HINDIBIO share price is ₹N/A and the 52-week low is ₹N/A. These values are updated daily from NSE/BSE price data.
What factors affect the HindBio Science share price?
Key factors influencing HINDIBIO share price include quarterly earnings growth (Sales Growth: -100.00%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is HindBio Science a good stock for long-term investment?
HindBio Science shows a 5-year Profit Growth of 4.56% and an ROE of 11.76%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 3.05 before investing in HINDIBIO shares.
How does HindBio Science compare with its industry peers?
HindBio Science competes with major peers in the Software Products. Investors should compare HINDIBIO share price P/E of 297.13x and ROE of 11.76% against the industry averages to determine competitive standing.
What is the P/E ratio of HINDIBIO and what does it mean?
HINDIBIO share price has a P/E ratio of 297.13x compared to the industry average of 36.75x. Investors pay ₹297 for every ₹1 of annual earnings.
How is HINDIBIO performing according to Bull Run's analysis?
HINDIBIO has a Bull Run fundamental score of N/A/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does HINDIBIO belong to?
HINDIBIO operates in the Software Products industry. This classification helps understand the competitive landscape and sector-specific trends affecting HindBio Science share price.
What is Return on Equity (ROE) and why is it important for HINDIBIO?
HINDIBIO has an ROE of 11.76%, which shows decent profitability but room for improvement. ROE measures how efficiently HindBio Science generates profits from shareholders capital.
How is HINDIBIO debt-to-equity ratio and what does it indicate?
HINDIBIO has a debt-to-equity ratio of 3.05, which indicates high leverage that increases financial risk.
What is HINDIBIO dividend yield and is it a good dividend stock?
HINDIBIO offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in HindBio Science shares.
How has HINDIBIO share price grown over the past 5 years?
HINDIBIO has achieved 5-year growth rates of: Sales Growth -16.03%, Profit Growth 4.56%, and EPS Growth 4.56%.
What is the promoter holding in HINDIBIO and why does it matter?
Promoters hold 12.19% of HINDIBIO shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in HindBio Science.
What is HINDIBIO market capitalisation category?
HINDIBIO has a market capitalisation of ₹6 crores, placing it in the Small-cap category.
How volatile is HINDIBIO stock?
HINDIBIO has a beta of N/A. A beta > 1 suggests the HindBio Science stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is HINDIBIO operating profit margin trend?
HINDIBIO has a 5-year average Operating Profit Margin (OPM) of -31.13%, indicating the company's operational efficiency.
How is HINDIBIO quarterly performance?
Recent quarterly performance shows HindBio Science YoY Sales Growth of -100.00% and YoY Profit Growth of -175.00%.
What is the institutional holding pattern in HINDIBIO?
HINDIBIO has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the HindBio Science stock.